Hong Kong Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

---

Industry Assessment Overview

Industry Findings: The territory’s health strategy is shifting toward tighter eHealth integration and clearer medical-device procurement rules, raising the premium on interoperability and supplier compliance. Recent Legislative Council briefings on eHealth+ and the broader eHealth development plan (Oct-2025) show policymakers pressing for territorial data portability and clearer device-to-eHR interfaces, which makes interoperability readiness a procurement gate for both public and private hospitals.

Industry Progression: A concrete, market-moving administrative step was the Hospital Authority’s 2024–25 budget formulation and related procurement planning (Feb-2024), which underpinned a wave of tenders and vendor engagements for imaging, sterilization and digital-health projects during 2024. That Feb-2024 budget activity translated into specific HA and Department of Health tenders (digital radiography, disinfection equipment), creating near-term demand for integrated device-and-service offers.

Industry Player Insights: With many companies present in the space, some are Philips Healthcare, Roche Diagnostics, Siemens Healthineers, and BGI Group etc. Vendor strategies are pivoting to meet HA procurement cycles: Philips’ enterprise imaging emphasis in its 2024 filings (2024) and BGI’s expanded regional sequencing capabilities (2024 milestones) support Hong Kong providers’ demand for integrated imaging and sequencing services. These developments benefit suppliers able to combine hardware, software interfaces and local service.